BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35118388)

  • 1. Intralipid therapy and adverse reproductive outcome: is there any evidence?
    Kumar P; Marron K; Harrity C
    Reprod Fertil; 2021 Jul; 2(3):173-186. PubMed ID: 35118388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.
    Singh N; Davis AA; Kumar S; Kriplani A
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():45-51. PubMed ID: 31228675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralipid treatment for women with reproductive failures.
    Coulam CB
    Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
    Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
    J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer.
    Check JH; Check DL
    Clin Exp Obstet Gynecol; 2016; 43(1):14-5. PubMed ID: 27048011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intralipid on pregnancy outcomes in women with previous implantation failure in in vitro fertilization/intracytoplasmic sperm injection cycles: A systematic review and meta-analysis.
    Zhou P; Wu H; Lin X; Wang S; Zhang S
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():187-192. PubMed ID: 32622103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of immunomodulation therapy in women with recurrent implantation failure undergoing assisted conception: A multicentre cohort study.
    Khairy M; Harb H; Eapen A; Melo P; Kazem R; Rajkhowa M; Ndukuwe G; Coomarasamy A
    Am J Reprod Immunol; 2024 Feb; 91(2):e13819. PubMed ID: 38348954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
    Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
    Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
    Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralipid infusion at time of embryo transfer in women with history of recurrent implantation failure: A systematic review and meta-analysis.
    Rimmer MP; Black N; Keay S; Quenby S; Al Wattar BH
    J Obstet Gynaecol Res; 2021 Jun; 47(6):2149-2156. PubMed ID: 33754451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralipid® may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation.
    Lédée N; Vasseur C; Petitbarat M; Chevrier L; Vezmar K; Dray G; Chenière S; Lobersztajn A; Vitoux D; Cassuto GN; Chaouat G
    J Reprod Immunol; 2018 Nov; 130():18-22. PubMed ID: 30286362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).
    Ata B; Abou-Setta AM; Seyhan A; Buckett W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011809. PubMed ID: 29489026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.
    Potdar N; Gelbaya TA; Konje JC; Nardo LG
    Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure.
    Martini AE; Jasulaitis S; Fogg LF; Uhler ML; Hirshfeld-Cytron JE
    J Hum Reprod Sci; 2018; 11(3):261-268. PubMed ID: 30568356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure: a systematic review and meta-analysis.
    Vitagliano A; Saccardi C; Noventa M; Di Spiezio Sardo A; Saccone G; Cicinelli E; Pizzi S; Andrisani A; Litta PS
    Fertil Steril; 2018 Jul; 110(1):103-112.e1. PubMed ID: 29908776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of immunotherapy in in vitro fertilization and recurrent pregnancy loss: a systematic review and meta-analysis.
    Achilli C; Duran-Retamal M; Saab W; Serhal P; Seshadri S
    Fertil Steril; 2018 Nov; 110(6):1089-1100. PubMed ID: 30396553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells.
    Dakhly DM; Bayoumi YA; Sharkawy M; Gad Allah SH; Hassan MA; Gouda HM; Hashem AT; Hatem DL; Ahmed MF; El-Khayat W
    Int J Gynaecol Obstet; 2016 Dec; 135(3):324-327. PubMed ID: 27614789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial.
    Al-Zebeidi J; Agdi M; Lary S; Al-Obaid S; Salim G; Al-Jaroudi D
    Gynecol Endocrinol; 2020 Feb; 36(2):131-134. PubMed ID: 31220957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.